NCT06271018View on ClinicalTrials.gov

TocILizumab in aorTitis in GCA (TILT)

RecruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

March 27, 2024

Primary Completion Date

September 27, 2026

Study Completion Date

March 27, 2028

Conditions
AortitisGiant Cell Arteritis (GCA)
Trial Locations (1)

75013

RECRUITING

Département de Medecine interne et d'immunologie clinique - hôpital La Pitié Salpetrière, Paris

All Listed Sponsors
lead

Groupe français d'étude des Maladies Inflammatoires de loeil

OTHER